Genmab A (GMAB) Non-Current Deferred Tax Liability (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Genmab A (GMAB) has disclosed Non-Current Deferred Tax Liability for 1 consecutive years, with $330.0 million as the latest value for Q4 2024.

• For the quarter ending Q4 2024, Non-Current Deferred Tax Liability changed N/A year-over-year to $330.0 million, compared with a TTM value of $330.0 million through Dec 2024, changed N/A, and an annual FY2024 reading of $330.0 million, changed N/A over the prior year.
• Non-Current Deferred Tax Liability was $330.0 million for Q4 2024 at Genmab A.
• Across five years, Non-Current Deferred Tax Liability topped out at $330.0 million in Q4 2024 and bottomed at $330.0 million in Q4 2024.

Peer Comparison